{
    "clinical_study": {
        "@rank": "9938", 
        "acronym": "ROLOCO", 
        "arm_group": [
            {
                "arm_group_label": "Rosuvastatin", 
                "arm_group_type": "Active Comparator", 
                "description": "A 40 mg loading dose of rosuvastatin was administrated 24 h before the PCI."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "A loading dose of placebo was administrated 24 h before the PCI."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the present study was to evaluate the effect of pre-procedural single high\n      loading dose (40 mg) of rosuvastatin on the primary end-points of all cause mortality and\n      composite of death or myocardial infarction from cardiovascular (CV) causes, target vessel\n      revascularization (TVR), or stroke."
        }, 
        "brief_title": "ROsuvastatin LOading and Clinical Outcomes Trial", 
        "completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "condition": "Atherosclerosis", 
        "condition_browse": {
            "mesh_term": "Atherosclerosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  statin-naive patients\n\n          -  stable ischemic heart disease\n\n          -  de novo lesions appropriate for PCI\n\n        Exclusion Criteria:\n\n          -  current statin use\n\n          -  statin allergic patients\n\n          -  acute coronary syndromes\n\n          -  lesions not appropriate for PCI\n\n          -  refusal for participation\n\n          -  statin quitting during follow- up"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "299", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01936805", 
            "org_study_id": "2173862"
        }, 
        "intervention": {
            "arm_group_label": "Rosuvastatin", 
            "description": "A 40 mg loading dose of rosuvastatin was administrated 24 h before the PCI.", 
            "intervention_name": "Rosuvastatin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Rosuvastatin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 2, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ankara", 
                    "country": "Turkey", 
                    "state": "Altindag", 
                    "zip": "06100"
                }, 
                "name": "Yuksek Ihtisas Hospital"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "all cause death and composite of death or myocardial infarction from CV causes, TVR, or stroke", 
            "safety_issue": "No", 
            "time_frame": "4 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01936805"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yuksek Ihtisas Hospital", 
            "investigator_full_name": "Serkan Cay", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "all cause death", 
                "safety_issue": "No", 
                "time_frame": "4 year"
            }, 
            {
                "measure": "composite of death or myocardial infarction from CV causes, TVR, or stroke", 
                "safety_issue": "No", 
                "time_frame": "4 year"
            }
        ], 
        "source": "Yuksek Ihtisas Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yuksek Ihtisas Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}